Purchase Order HHSF223201300936P

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $33,560 purchase order to Antibodies Incorporated for two monoclonal antibody projects. Antibodies Incorporated, doing business as Antibodies Inc., will deliver the requested monoclonal antibodies from its Bethesda, Maryland facility within the one-month period of performance ending September 30, 2023. As the prime contractor, Antibodies Inc. will be responsible for completion of the two...

The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $78,507.00 firm-fixed-price contract to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, for Genscript Monoclonal Antibodies and Plasmid Services. This sole-source contract supports NIAID's Laboratory of Immunogenetics (LIG), which is expanding its work on isolating human monoclonal antibodies against COVID-19, malaria, and tuberculosis. The contract...

This is a firm-fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to A&G Pharmaceutical, Inc. (doing business as Precision Antibody). The contract is for the preparation of monoclonal antibodies against the MARCH1 protein, with a ceiling value of $16,900.00 and a performance period through July 31, 2025. A&G Pharmaceutical is a for-profit manufacturer of biological...

This is a $13,062.24 firm fixed-price contract awarded by the Food and Drug Administration (FDA) to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for Genscript to provide monoclonal antibody (MOAB) development services, with a final completion date of September 9, 2025. This appears to be a definitive contract and does not have a set-aside designation. Genscript is a well-established federal contractor, having received numerous awards from agencies like...

The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a $38,454 firm-fixed price contract to Bio-Rad AbD Serotec GmbH, a subsidiary of Bio-Rad Laboratories, Inc., to provide lab testing services for custom monoclonal recombinant antibodies generated through HuCAL technology. The contract will support the generation of monoclonal recombinant antibodies that the NIAID lab will use for in-vitro...

This federal contract award to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, is for the delivery of custom rabbit monoclonal antibodies to support the development of diagnostic tests for taeniasis and cysticercosis. The award, valued at $49,981.00, was made by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia and has a period of performance from September 30, 2024 to April 22, 2025. The original solicitation, a Request for Quotations (RFQ), was...

This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging to A&G Pharmaceutical, Inc. (doing business as Precision Antibody), a for-profit manufacturer of goods. The $14,630.25 contract is for the development of monoclonal antibodies to support biomedical research. Precision Antibody has provided similar services to HHS components like the National Cancer Institute and Department of...

The National Institutes of Health National Institute of Allergy and Infectious Diseases (NIH NIAID) awarded a $59,541 firm fixed price purchase order to Genscript USA Inc. to provide customized antibody synthesis, expression, purification, and plasmid preparations in support of the Laboratory of Malaria Immunology and Vaccinology's (LMIV) malaria vaccine research. Per the original solicitation, LMIV requires custom monoclonal antibodies that can label and sort immune cell subsets in its colony...

This is a $97,722.00 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of monoclonal antibodies and plasmids services to support NIAID's research initiatives, with a completion date of September 19, 2025. This contract is not designated as a set-aside....

This is a $180,000 fixed-price purchase order awarded by the Defense Health Agency (DHA) to Genovac Antibody Discovery LLC, a small disadvantaged business, to provide human monoclonal antibody (mAb) development services. The contract supports the Walter Reed Army Institute of Research (WRAIR) and Armed Forces Research Institute of Medical Sciences (WRAIR-AFRIMS) and includes performing feasibility studies, developing and producing a panel of fully human mAbs, and shipping the mAbs to AFRIMS...